NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Lykiri, 56 met+, 121 met-, and 32 of the first 38 contingent dying before they reached 36 months on trial, comes to a total of 209 patients. Am I right to presume that since there were 108 survivors at 3/17, the remaining 223 were either dead or LTFU? If there were 9-11 LTFU, the remaining 212-214 patients were dead. If 209 patients died before they reached that 36 months timeline that only leaves 3-5 patients (212-209 or 214-209) who died after 36 months on trial. That seems like a very small number of fatalities occurring after 36 months.

I am not clear how the 9-11 LTFU are handled statistically and the answer to that that may (or may not) help to answer to my question.